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Background and purpose: No information is available concerning the effects of anaesthetics in the most frequently used
in vivo pro-arrhythmia model. Accordingly, in this study we examined the effect of pentobarbital, propofol or a-chloralose
anaesthesia on the pro-arrhythmic activity of the class III anti-arrhythmic dofetilide in a1-adrenoceptor-stimulated rabbits.
Experimental approach: Rabbits anaesthetized intravenously with pentobarbital, propofol or a-chloralose were infused
simultaneously with the a1-adrenoceptor agonist phenylephrine (15mg kg
1 min1, i.v.) and dofetilide (0.04 mg kg1 min1,
i.v.). The electrocardiographic QT interval, the Tpeak–Tend interval and certain QT variability parameters were measured. The
heart rate variability and the baroreflex sensitivity were utilized to assess the vagal nerve activity. The spectral power of the
systolic arterial pressure was calculated in the frequency range 0.15–0.5 Hz to assess the sympathetic activity.
Key results: Pentobarbital considerably reduced, whereas propofol did not significantly affect the incidence of dofetilide-
induced torsades de pointes (TdP) as compared with the results with a-chloralose (40% (P¼0.011) and 70% (P¼0.211) vs
100%, respectively). In additional experiments, neither doubling of the rate of the dofetilide infusion nor tripling of the rate of
phenylephrine infusion elevated the incidence of TdP to the level seen with a-chloralose. None of the repolarization-related
parameters predicted TdP. The indices of the parasympathetic and sympathetic activity were significantly depressed in the
a-chloralose and propofol anaesthesia groups.
Conclusions and implications: In rabbits, anaesthetics may affect drug-induced TdP genesis differently, which must be
considered when results of different studies are compared.
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Abbreviations: ECG, electrocardiogram; PNN8, percentage of successive QT intervals that differ by more than 8 ms; RMSSD,
root mean square of the successive differences in the RR or QT intervals; SAP MF, spectral power of the systolic
arterial pressure in the mid-frequency range
Introduction
The long QT syndrome is caused either by inherited
‘channelopathies’ or by acquired factors, for example cardiac
or non-cardiac drugs that hinder the process of repolariza-
tion of the myocytes. The most dangerous consequence of
the disturbed repolarization is the occurrence of a poly-
morphic ventricular tachycardia known as torsades de
pointes, which can deteriorate into ventricular fibrillation.
Thus, the pro-arrhythmic liability of any drug under
development must be assessed so as to avoid the occurrence
of drug-induced life-threatening arrhythmias, for example
torsades de pointes, during pharmacotherapy (Thomsen
et al., 2006).
The most commonly used animal model for the in vivo
screening of drug-induced pro-arrhythmia is the a1-adreno-
ceptor-stimulated anaesthetized rabbit model of the acquired
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long QT syndrome developed by Carlsson et al. (1990).
During the development of the model, it was found that
low doses of the class III anti-arrhythmic almokalant readily
evoked torsades de pointes in conscious rabbits but when
rabbits were anaesthetized with a-chloralose, torsades de
pointes was rarely seen and if so, only at very high doses of
almokalant (Carlsson et al., 1993). This anti-arrhythmic
effect of a-chloralose anaesthesia was independent of its
effect on the heart rate and blood pressure and was
successfully counterbalanced by the administration of the
a1-adrenoceptor-stimulant methoxamine (Carlsson et al.,
1993). Later, the rabbit model with the combination of
a-chloralose anaesthesia and a1-adrenoceptor-stimulation was
also used by other authors (see Buchanan et al., 1993; Farkas
et al., 1998). However, the poor solubility of a-chloralose and
its very slow induction of anaesthesia led others to try
different intravenous anaesthetics, for example pentobarbi-
tal (Bril et al., 1996; Batey and Coker, 2002) or a mixture of
ketamine and xylazine (Mazur et al., 1999). Although the
a1-adrenoceptor-stimulated anaesthetized rabbit model of
the acquired long QT syndrome has been widely used to
assess the pro-arrhythmic liability of novel anti-arrhythmics
and other non-cardiac agents, direct comparison of the effect
of the applied anaesthetics on the pro-arrhythmic activity of
the test drug has not been performed as yet.
Pentobarbital is a frequently used intravenous anaesthetic
in experimental studies in vivo as it provides fast induction
and the reliable maintenance of anaesthesia. In earlier
studies, pentobarbital reduced the incidence of drug-induced
torsades de pointes in arterially perfused canine left
ventricular wedge preparations (Shimizu et al., 1999) and
in dogs in vivo (Weissenburger et al., 2000; Yamamoto et al.,
2001; Voss et al., 2002). This suggests that pentobarbital
anaesthesia might well reduce the incidence of drug-induced
torsades de pointes in rabbits too, but this has not been
studied to date.
Propofol is one of the most frequently used short-acting
intravenous anaesthetics in intensive care units. A recent
case report described that propofol abolished recurrent
ventricular tachycardia called ‘electrical storm’ in an elderly
patient, probably by suppressing sympathetic activity
(Burjorjee and Milne, 2002). In the review by Booker et al.
(2003), it was suggested that, despite the very limited
number of data available on the drug, propofol might be a
useful agent for the anaesthesia of patients with the long QT
syndrome. However, the effect of propofol on drug-induced
torsades de pointes has never been tested.
The aim of the present study was to examine whether
pentobarbital anaesthesia or propofol anaesthesia reduces
the pro-arrhythmic activity of the class III anti-arrhythmic
dofetilide as compared with that seen with standard a-
chloralose anaesthesia in the rabbit model of the acquired
long QT syndrome. An attempt was made to determine
whether the effects of the anaesthetics on the pro-arrhythmic
activity of dofetilide were related to any effect on the basic
haemodynamics (that is, the blood pressure and the heart
rate), the repolarization-related parameters or the autonomic
nervous system. The assessment of the repolarization-related
parameters of the animals included measurement of the
electrocardiographic QT and the rate-corrected QT intervals,
the Tpeak–Tend intervals and the calculation of certain QT
variability parameters. The activity of the parasympathetic
arm of the autonomic nervous system of the animals was
assessed via measurement of the ‘heart rate variability’ and
the baroreflex sensitivity of the spontaneous baroreflex
sequences. The activity of the sympathetic nervous system
of the animals was estimated by calculating the spectral
power of the systolic arterial pressure in the appropriate
frequency range.
Since pentobarbital reduced the incidence of dofetilide-
induced torsades de pointes in the present study, a second set
of experiments was performed to examine whether increase
of the dose (and the rate of infusion) of dofetilide or the
sensitizing a1-adrenoceptor stimulant phenylephrine could




The animals were handled in accordance with the European
Community guidelines for the use of experimental animals,
and the protocol was reviewed and approved in advance
by the Ethical Committee for the Protection of Animals in
Research at the University of Szeged, Hungary. The effects of
different intravenous anaesthetics on the pro-arrhythmic
activity of dofetilide were examined by using the method of
Carlsson et al. (1990) with minor modifications. The
experiments were performed on female New Zealand White
rabbits weighing 2.61±0.04 kg.
Anaesthesia of the rabbits
The animals were randomly allocated to one or other of the
three anaesthesia groups, with 10 rabbits in each group. A
catheter was introduced into the marginal vein of the left ear
for blood sampling and anaesthesia induction. One millilitre
of blood was withdrawn via the catheter to determine serum
Kþ concentration of the conscious animal. After blood
sampling, the animals were anaesthetized intravenously
with a-chloralose, or propofol, or pentobarbital. The planned
dose of a-chloralose was 90 mg kg1 i.v. (Carlsson et al.,
1990), but 147±5 mg kg1 (10 mg ml1, 1 ml min1) of
anaesthetic was needed to achieve sufficiently deep anaes-
thesia. Propofol anaesthesia was induced with an i.v. bolus
of 10 mg kg1 of propofol (Aeschbacher and Webb, 1993a),
which was followed by an i.v. maintenance infusion of the
drug. The planned rate of the maintenance infusion of
propofol was 1 mg kg1 min1 (Aeschbacher and Webb,
1993b), but it was necessary to elevate the rate of infusion
of the drug to 1.29±0.10 mg kg1 min1 so as to achieve
sufficiently deep anaesthesia. Similarly, the planned dose of
pentobarbital for anaesthesia was 30 mg kg1 i.v. (Farkas and
Coker, 2002), but 42±2 mg kg1 (30 mg ml1; 1 ml min1)
was needed for sufficiently deep anaesthesia. In the second
set of experiments (for the details, see the Experimental
protocol section), two additional groups of animals with 10
rabbits in each group were anaesthetized with intravenous
pentobarbital; anaesthesia was induced with 34±2 and
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33±3 mgkg1 of pentobarbital in the first (‘double dofetilide’)
and the second (‘triple phenylephrine’) group, respectively.
The depth of the anaesthesia was carefully assessed
throughout the experiment. The surgical preparation of the
animals started only when the pedal withdrawal reflex had
disappeared and there was no response to pinching of the
ears of the animal. The dose of each anaesthetic adminis-
tered for induction was adjusted to the need of the animal.
Anaesthesia induction lasted much longer in the animals
anaesthetized with a-chloralose as compared with the other
anaesthesia groups (B40 min in the chloralose group vs
3–4 min in the propofol and the pentobarbital-anaesthetized
groups). The induction of anaesthesia depressed the rate of
spontaneous breathing from B60 to 20–30 min1 in each
animal, independently of the anaesthetic applied.
When there was any sign of pain or consciousness, extra
boluses of the anaesthetics were administered during the
surgical preparation and during the protocol. Only one of
the 10 animals needed an additional 20 mg of a-chloralose
after anaesthesia induction. An extra bolus of propofol
(10–100 mg) was administered several times to the first four
animals in the ‘propofol’ group during the experiments,
which proved that the planned maintenance dose of
propofol (1 mg kg1 min1) was insufficient. An extra bolus
of 6–9 mg pentobarbital was administered to the animals
when the pentobarbital anaesthesia was not deep enough
after induction, which occurred in 20 of the 30 pentobarbital-
anaesthetized rabbits; these animals needed a total of
25±2 mg extra pentobarbital after induction during the
experiments, overall.
Surgical preparation
A catheter was introduced into the right carotid artery to
measure blood pressure. The catheter was filled with
heparin-treated saline (0.9% w/v NaCl containing 15 IU ml1
heparin) and connected to a pressure transducer of a
PowerLab computerized data acquisition system (ADInstruments
Inc., Colorado Springs, CO, USA). Blood pressure signal was
recorded at a sampling rate of 1000 Hz by the PowerLab
System. Two other catheters were introduced into the right
jugular vein and the marginal vein of the right ear for the
infusion of drugs. After tracheal cannulation, artificial
ventilation was started (Harvard rodent ventilator, model
683, Harvard Apparatus, South Natick, MA, USA) with room
air at a rate of 40 strokes per min, a stroke volume of B6 ml
(kg body weight)1 and a positive end-expiratory pressure of
1–2 cm H2O. Blood gases were monitored with a Radiometer
ABL 725 pH/blood gas analyser (Radiometer Medical ApS,
Copenhagen, Denmark). If necessary, the stroke volume of
the ventilation pump and the positive end-expiratory
pressure were adjusted to maintain the blood gases within
the normal range. Subcutaneous needle electrodes were
inserted in all four limbs, and Leads I–III of the electro-
cardiogram (ECG) were recorded simultaneously at a sam-
pling rate of 1000 Hz with the PowerLab System. The
preparation was followed by a minimum 10-min stabilizing
period.
Experimental protocol
In the first set of experiments, the rabbits were anaesthetized
randomly with a-chloralose, or propofol, or pentobarbital
(there were 10 rabbits in each anaesthesia group; for the
details see the Anaesthesia section). After a 10-min baseline
period, infusion of the a1-adrenoceptor agonist phenylephrine
was started at increasing rates (that is, 3, 6, 9, 12 and
15 mg kg1 min1 for 3, 3, 3, 3 and 5 min, respectively). From
the 27th minute, dofetilide (0.04 mg kg1 min1 i.v., for
45min) was administered simultaneously with the background
phenylephrine infusion (at a rate of 15 mg kg1 min1) until
the end of the experiments (Figure 1a). Although the
infusion rate of dofetilide is far beyond the clinically relevant
dosing, this extremely high infusion rate of the drug was
chosen as dofetilide infusion at this rate induced torsades de
pointes frequently and reproducibly in a1-adrenergically
stimulated, a-chloralose-anaesthetized rabbits (Lu et al.,
2001).
In the second set of experiments, only pentobarbital was
applied to anaesthetize the rabbits. In the first group of
animals (10 rabbits), the previous phenylephrine infusion
protocol was used, but the rate of dofetilide infusion was
Figure 1 Drug administration protocol. (a) The anaesthetic agent
is a-chloralose, or propofol, or pentobarbital. Phenylephrine is
administered at increasing rates (3, 6, 9, 12 and 15mg kg1 min1).
Dofetilide is infused at a rate of 0.04 mg kg1 min1. (b) Drug
administration protocol in the ‘double dofetilide’ group. The
anaesthetic agent is pentobarbital. Phenylephrine is administered
at increasing rates (3, 6, 9, 12 and 15mg kg1 min1). Dofetilide is
infused at a rate of 0.08 mg kg1 min1. (c) Drug administration
protocol in the ‘triple phenylephrine’ group. The anaesthetic agent
is pentobarbital. Phenylephrine is administered at increasing rates
(3, 6, 9, 12, 15 and 45mg kg1 min1). Dofetilide is infused at a rate
of 0.04 mg kg1 min1.
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doubled (that is, 0.08 mg kg1 min1 for 45 min from the
27th minute; ‘double dofetilide’ group; Figure 1b). In the
second group of animals (10 rabbits), the lower rate of
dofetilide infusion (0.04 mg kg1 min1 for 45 min) was used,
but the rate of the background phenylephrine infusion
was tripled (45 mg kg1 min1; ‘triple phenylephrine’ group;
Figure 1c).
Electrocardiogram analysis and arrhythmia diagnosis
The blood pressure and the ECG intervals were measured at
predetermined time points. After completion of the experi-
ments, the data were replayed and the RR, PQ, QRS and QT
intervals were measured by the manual positioning of
on-screen markers. The QT interval measurement was
performed as described previously by Farkas et al. (2004).
Briefly, the QT interval was defined as the time between the
first deviation from the isoelectric line during the PQ
interval until the end of the TU wave. The T (or U) waves
frequently overlapped the P wave of the following sinus-
origin beat, due to the relatively high heart rate of the rabbit
or to substantial QT prolongation. In these cases, the
extrapolation method was used (Farkas et al., 2004), that is
the end of the TU wave was extrapolated from the curve of
the TU wave to the isoelectric line under the P wave. All
the values for the QT interval were corrected for the heart
rate by two different methods, with the equation
QTcC¼QT0.175(RR300) developed to correct the QT
intervals of rabbits anaesthetized with a-chloralose
(Carlsson et al., 1993), or with the equation QTcL¼
QT0.704(RR250) developed for pentobarbital-anaesthe-
tized rabbits (Batey and Coker, 2002). The Tpeak–Tend interval
was measured according to Antzelevitch and Oliva (2006) in
the standard limb Lead II of the ECG in the last minute
before the start of the phenylephrine infusion (baseline), in
the last minute before the start of the dofetilide infusion and
in the 4th minute of the dofetilide infusion (further
measurements were prevented by the frequent occurrence
of dofetilide-induced arrhythmias). When the end of the
Tpeak–Tend interval overlapped the following P wave, the
extrapolation method (Farkas et al., 2004) was applied. Four
consecutive Tpeak–Tend intervals were measured and averaged
at each time point.
From the ECG, the incidence, the time to onset and the
duration of ventricular arrhythmias were obtained. Ventri-
cular premature beats, bigeminy, salvos and ventricular
fibrillation were defined according to the Lambeth Conven-
tions (Walker et al., 1988). When continuous ventricular
fibrillation lasted longer than 120 s, the experiment was
terminated and the ventricular fibrillation was defined as
lethal. Torsades de pointes was defined as a polymorphic
ventricular tachycardia where clear twisting of the QRS
complexes around the isoelectric axis could be seen in at
least one ECG lead. Runs of four or more ventricular
premature beats without the torsades-like twisting QRS
morphology were differentiated from torsades de pointes
and were defined as ventricular tachycardia. Blocks in the
conduction system were also monitored. Conduction dis-
turbances included atrioventricular blocks and intraventri-
cular conduction defects (right or left bundle branch blocks).
Measurement of the beat-to-beat variability of the QT intervals
and the RR intervals
The beat-to-beat variability of the QT intervals was deter-
mined from the manual measurement data on 30 consecu-
tive QT intervals and the corresponding RR intervals in sinus
rhythm at predetermined time points, that is in the last
minute of the drug-free state, in the last minute of the
phenylephrine infusion before the dofetilide administration
and in the 2nd–4th minute of the dofetilide infusion, when
arrhythmias were still infrequent. A computer program was
developed in a NET environment to obtain the following
parameters of the beat-to-beat variability of the QT intervals.
RMSSD and SDSD. One approach for characterization of the
beat-to-beat variability of the RR and QT intervals is to take
their successive differences and calculate the root mean
square (RMSSD) and the standard deviation (SDSD) of these
differences (Brennan et al., 2001).
PNN8. In human cardiovascular research, PNN50 (the
percentage of successive RR intervals that differ by more
than 50 ms) is a well-established measure of RR variability
(Copie et al., 1996). We adopted this idea and tailored the
difference criterion to the rabbit QT intervals. First, we chose
the value of the criterion on the basis of the ratio of an
average rabbit QT interval to a typical human RR interval
duration, and then decreased it, because the QT interval
variation for some specimens did not reach the original limit
at all. Finally, we settled arbitrarily a value of 8 ms, that is
PNN8 is the percentage of successive QT intervals that differ
by more than 8 ms.
Instability. Following the definition by Hondeghem et al.
(2001), the instability of the RR and QT intervals was
calculated as the difference between the upper quartile (the
upper boundary of the lowest 75% of the interval values) and
the lower quartile (the upper boundary of the lowest 25% of
the interval values).
Short-term variability. In terms of a Poincaré plot, which is a
plot of RR or QT intervals (diþ1) against the preceding RR or
QT values (di), the short-term variability, introduced by
Thomsen et al. (2004), can be visualized as the mean
perpendicular distance between the points of the plot and
the diþ1¼ di line.
Long-term variability. In the framework outlined above,
long-term variability is the mean distance (measured parallel
to the line diþ1¼ di in the Poincaré plot) between the
individual RR or QT interval durations (di) and their mean
value (E(d)) (Thomsen et al., 2004).
QT variability index. QT variability index, introduced by
Berger et al. (1997), was calculated as the logarithmic ratio of
the QT variance and the heart rate variance, each normalized
by the respective mean.
The beat-to-beat variability of the RR interval was analysed
with a computer software (WinCPRS; Absolute Aliens Oy,
Turku, Finland); the analysis was performed in the ECG
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section of the last 5 min of the drug-free period before the
phenylephrine infusion and the last 1 min of each rate of
phenylephrine infusion before the dofetilide administration
(see the Experimental protocol section and Figure 1). Only
the arrhythmia-free ECG sections were analysed. The soft-
ware calculated the mean and the s.d. of the RR intervals
together with RMSSD (see above) within a given experi-
mental period.
Analysis of the spontaneous baroreflex sequences
The baroreflex sensitivity, an index of the vagal nerve
activity, was evaluated by using the method of Bertinieri
et al. (1988) with minor modifications. The beat-to-beat time
series of the systolic arterial pressure and the RR interval were
analysed with the computer software WinCPRS (Absolute
Aliens Oy) to identify spontaneously occurring sequences of
X3 consecutive beats in which the systolic arterial pressure
and the RR interval of the following (that is, lag 1) beat
changed in the same direction, for example either increasing
or decreasing (that is, hypertension and bradycardia, or
hypotension and tachycardia, respectively). The threshold
changes between two consecutive systolic arterial pressures
and the RR interval values were set at 0.3 mm Hg and 0.1 ms,
respectively. Linear regression was applied to each individual
sequence, as in the Oxford technique, which uses bolus
injections of vasoactive drugs. Only those sequences in
which r240.7 were accepted. The percentage incidence of
the RR intervals that comprised spontaneous baroreflex
sequences was calculated in each analysed ECG section.
The mean individual slope of the baroreflex sequences,
obtained by averaging all the slopes computed within a
given experimental period, was calculated and taken as a
measure of the integrated spontaneous baroreflex sensitivity
for that period. Baroreflex analysis was performed in the last
5 min of the drug-free period and in the last 1 min of each
rate of phenylephrine infusion before the dofetilide admin-
istration (see the Experimental protocol section and
Figure 1). Few animals furnished spontaneous baroreflex
sequences for each rate of phenylephrine infusion, and there
were many arrhythmias during the phenylephrine infusion,
which hindered the baroreflex analysis. These two factors
together decreased the number of data obtained at each
phenylephrine rate, which did not allow statistical compar-
ison between the groups for every rate of phenyl-
ephrine infusion. Thus, only a single between-group analysis
was performed, using the pooled baroreflex sensitivity data
on all five 1-min time periods during the phenylephrine
infusion.
Spectral analysis of the variation in the systolic arterial blood
pressure and the duration of the RR intervals
Spectral analysis was performed with the arterial blood
pressure and the ECG signal of the animals recorded in
the last 5 min of the drug-free period and the 3 min of the
9 mg kg1 min1 phenylephrine infusion rate (see the
Experimental protocol section and Figure 1 for details).
The examined frequency-domain parameters were the
spectral powers in the low-, mid- and high-frequency ranges
of the systolic arterial pressure and the RR interval spectra.
The boundaries for the frequency ranges were as follows:
the low-frequency domain ranged from 0.025 to 0.15 Hz,
the mid-frequency domain from 0.15 to 0.5 Hz and the high-
frequency domain from 0.5 to 3 Hz. These frequency ranges
were chosen for the following reasons: in rabbits,
an approximately 0.3 Hz oscillation in the arterial blood
pressure has been identified, and spectral analysis
revealed strong increases in the power at 0.3 Hz of the renal
sympathetic nerve activity and of the blood pressure
when sympathetic stimuli were applied (Malpas and
Burgess, 2000). Thus, the spectral power of the systolic
arterial pressure measured in the vicinity of 0.3 Hz (in our
mid-frequency range) reflects the activity of the sympathetic
nervous system in rabbits. Furthermore, the high-frequency
component of the power spectrum of the RR interval
variability reflected the magnitude of fluctuation in the
cardiac vagal input associated with respiratory modulation
(Iwao et al., 2000), and the spectral power of the variability
of the RR interval was modulated by vagal influences at
frequencies o0.4373 Hz (Moguilevski et al., 1996). Thus,
the spectral power of the RR interval variability measured
in our high-frequency range reflects the activity of the
parasympathetic nervous system.
First, the R waves were identified in the ECG recordings
and the systolic arterial pressure peaks were identified in the
blood pressure signal to calculate the RR interval and the
systolic arterial pressure spectrum, respectively. The fast
discrete implementations of the Fourier transformation rely
on an evenly spaced data set; however, this is naturally not
the case with our RR interval and systolic arterial pressure
sequences. To fulfil the conditions of even spacing, the data
were ‘re-sampled’ by using spline interpolation to obtain the
intermediate RR interval or systolic arterial pressure values.
The power spectral density of the re-sampled data was then
calculated and the low-frequency (LF), mid-frequency (MF)














where Df denotes the frequency resolution in the discrete
spectrum and S the power spectral density of either the RR
interval or the systolic arterial pressure. The indices imin,
imax, jmin, jmax, kmin and kmax correspond to the boundaries of
the low-, mid- and high-frequency ranges:
imin Df ¼0:025 Hz
imax Df ¼0:15 Hz ¼ jmin Df
jmax Df ¼0:5 Hz ¼ kmin Df
kmax Df ¼3:0 Hz
The peak detection, the re-sampling and the calculation of
the spectra were performed in a LabVIEW 7.1 (National
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Instruments Corporation, Austin, TX, USA) programming
environment.
Statistical evaluation
Continuous data were expressed as mean±s.e.mean. All data
from independent samples, with the exception of arrhythmia
incidences, were compared with Kruskal–Wallis tests. Con-
tinuous data from the same sample were compared with
Wilcoxon tests. Arrhythmia incidences were compared by
using the Fisher’s exact probability test. Differences were
considered statistically significant when Po0.05.
Drugs
Dofetilide was a gift from EGIS Pharmaceuticals PLC
(Budapest, Hungary). All other drugs were purchased from
the following sources: a-chloralose and phenylephrine
(L-phenylephrine HCl) from Sigma Chemical Co. (Budapest,
Hungary); propofol (Diprivan 2%) from AstraZeneca (Mölndal,
Sweden); pentobarbital (sodium pentobarbital, Nembutal)
from Phylaxia-Sanofi (Budapest, Hungary); and heparin-
sodium from Gedeon Richter Ltd (Budapest, Hungary).
The solution of a-chloralose was obtained by dissolving
and boiling 400 mg of a-chloralose in 40 ml of 0.9% w/v
saline at 50–60 1C. The propofol solution was the original
‘Diprivan 2%’ solution without any further dilution. The
pentobarbital solution was prepared by adding 3 ml of
0.9% w/v saline to 3 ml of ‘Nembutal’ (6%) solution. The
phenylephrine solution was prepared by dissolving 9 mg of
L-phenylephrine HCl in 10 ml of 0.9% w/v saline. Increasing
doses of phenylephrine, that is 3, 6, 9, 12, 15 and
45 mg kg1 min1, were administered by infusing the given
phenylephrine solution at rates of 3.33, 6.67, 10.00, 13.33,
16.67 and 50.00 ml kg1 min1, respectively. The dofetilide
solution was prepared by dissolving 9.6 mg of dofetilide in
4 ml of solvent (consisting of 3.6 ml of waterþ0.4 ml of 1 M
NaOH); infusion of the dofetilide solution at a rate of
16.67 ml kg1 min1 resulted in the infusion of dofetilide at
0.04 mg kg1 min1. The same dofetilide solution was in-
fused into the animals in the ‘double dofetilide’ group, but
the infusion rate was then doubled, that is infusion of the
dofetilide solution at 33.33 ml kg1 min1 resulted in the
infusion of dofetilide at a rate of 0.08 mg kg1 min1. Each
solution was prepared freshly on the day of the experiment.
Results
Arrhythmia incidences and the onset time of torsades de pointes
Torsades de pointes and ventricular fibrillation never
occurred before the dofetilide infusion. In this period, the
phenylephrine infusion induced only a few premature
ventricular beats and no arrhythmias in the a-chloralose-
and propofol-anaesthetized animals, respectively. In con-
trast, non-complex arrhythmias, for example ventricular
premature beats and bigeminies, were evoked frequently in
the pentobarbital-anaesthetized animals before the dofeti-
lide administration. In the additional set of experiments
with the pentobarbital-anaesthetized animals, the high rate
of infusion of phenylephrine frequently induced both
complex and non-complex arrhythmias, but did not trigger
torsades de pointes or ventricular fibrillation before the
dofetilide infusion (Table 1).
Table 1 Incidence of arrhythmias before and during dofetilide infusion, onset time of torsades de pointes and pro-arrhythmic dose of dofetilide in
anaesthetized rabbits
Incidence of arrhythmias (%) TdP onset (min) TdP dose (mg kg1)
n VPB BG Salvo Block VT TdP VF SVF
Before dofetilide
Chloralose 10 10 0 0 0 0 0 0 0
Propofol 10 0 0 0 0 0 0 0 0
Pentobarbital 10 50# 60*,# 20 0 0 0 0 0
Dof2x 10 50# 30 40 0 20 0 0 0
Phe3x 10 100w 80*,# 100w 70w 100w 0 0 0
During dofetilide
Chloralose 10 100 100 100 90 100 100 20 20 7.79±0.84 0.31±0.03
Propofol 10 80 80 70 80 70 70 40 30 7.66±2.31 0.31±0.09
Pentobarbital 10 90 100 100 80 100 40* 0 0 10.66±3.45 0.43±0.14
Dof2x 10 100 100 100 100 100 70 40 10 6.53±2.68 0.52±0.21
Phe3x 10 80 80 60 80 100 20* 0 0 4.68±1.15 0.19±0.05
Incidence values are percentage incidences of arrhythmias; Before dofetilide, arrhythmia incidences when only phenylephrine infusion was administered; During
dofetilide, arrhythmia incidences, torsades de pointes onset times and pro-arrhythmic doses of dofetilide when phenylephrine and dofetilide infusions were
administered simultaneously; Chloralose, group of animals anaesthetized with a-chloralose; Propofol, group of animals anaesthetized with propofol; Pentobarbital,
group of animals anaesthetized with pentobarbital; Dof2x, group of animals anaesthetized with pentobarbital, and dofetilide is infused at a rate of
0.08 mg kg1 min1 (‘double dofetilide’ group; see Figure 1 for protocol); Phe3x, group of animals anaesthetized with pentobarbital, and the maximum
phenylephrine infusion rate is 45mg kg1 min1 (‘triple phenylephrine’ group; see Figure 1 for protocol); VPB, ventricular premature beat; BG, bigeminy; Block,
conduction block of any kind; VT, ventricular tachycardia different from torsades de pointes; TdP, torsades de pointes ventricular tachycardia; VF, ventricular
fibrillation; SVF, sustained ventricular fibrillation, that is ventricular fibrillation that lasts 4120 s; TdP onset, the onset time of torsades de pointes after commencing
dofetilide infusion; TdP dose, the cumulative dose of dofetilide that triggered torsades de pointes; n, group size.
*Po0.05 vs the ‘Chloralose’ group; #Po0.05 vs the ‘Propofol’ group; wPo0.05 vs all other groups.
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Dofetilide frequently evoked ventricular premature beats,
bigeminies, salvos, conduction blocks and non-torsades
de pointes ventricular tachycardias, independently of the
anaesthetic applied (Table 1). Dofetilide induced torsades de
pointes in all the animals anaesthetized with a-chloralose,
and a majority of the propofol-anaesthetized animals
exhibited this arrhythmia during the dofetilide infusion
(Figure 2). In contrast, torsades de pointes was evoked in
less than half of the pentobarbital-anaesthetized animals
(Table 1). In the additional set of experiments with the
pentobarbital-anaesthetized rabbits, neither the doubling of
the dofetilide infusion rate nor the tripling of the phenyl-
ephrine infusion rate elevated the incidence of torsades de
pointes to the level seen in the animals anaesthetized with
a-chloralose (Table 1).
There was no statistical difference between the onset times
of torsades de pointes in the various groups (Table 1).
Similarly, there was no significant difference between the
cumulative doses of dofetilide that triggered torsades de
pointes in the various groups (Table 1).
Blood pressure
The baseline blood pressure values associated with the
pentobarbital anaesthesia were significantly higher as com-
pared with the values measured in the animals anaesthetized
with a-chloralose or propofol (Table 2). Stepwise elevation of
the rate of infusion of phenylephrine increased the blood
pressure before the dofetilide infusion. Interestingly, the
anaesthesia-related difference in the baseline of blood
pressure values disappeared soon after the start of the
phenylephrine infusion, that is the blood pressures rose
more steeply in the a-chloralose- and the propofol-
anaesthetized animals at low and intermediate phenylephrine
infusion rates. After they had caught up, the blood pressure
values rose similarly in all groups during the high rates of
infusion of phenylephrine before the dofetilide administra-
tion (Table 2). In the additional set of experiments with the
pentobarbital-anaesthetized rabbits, the application of the
threefold phenylephrine infusion rate (45 mg kg1 min1)
resulted in higher maximum blood pressure values relative
to those measured in the animals that received the
phenylephrine infusion at the earlier maximum rate of
15 mg kg1 min1 (Table 2). During the dofetilide infusion,
the blood pressures decreased in parallel in all the groups,
but the blood pressure always remained higher in the ‘triple
phenylephrine’ group as compared with all the other groups
(Table 2).
Heart rate and ECG intervals
Unlike the blood pressure, the baseline heart rate values did
not differ in the different anaesthesia groups. Phenylephrine
mildly reduced the heart rates and prolonged the QT
intervals in the a-chloralose- and pentobarbital-anaesthe-
tized groups before the dofetilide infusion, but there were
no differences in the heart rates and the QT intervals in
the groups immediately before the start of the dofetilide
infusions (Table 3). Arrhythmias occurred frequently in all
animals approximately 5 min after the start of the dofetilide
administration, which prevented measurement of the sinus
heart rate and the ECG intervals thereafter. Following the
start of the dofetilide administration, arrhythmias occurred
instantly in the animals in the ‘double dofetilide’ group,
preventing subsequent measurements of the sinus heart rate
and the ECG intervals. Similarly, in consequence of the
frequent occurrence of arrhythmias induced by the highest
rate of phenylephrine infusion, sinus heart rates and ECG
intervals could not be measured in the animals in the ‘triple
phenylephrine’ group.
Figure 2 An example of dofetilide-induced torsades de pointes ventricular tachycardia (TdP). ECG I–III, electrocardiogram Leads I–III; BP,
arterial blood pressure; Block, intraventricular conduction block; VT, polymorphic ventricular tachycardia different from torsades de pointes.
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The dofetilide infusion quickly and markedly prolonged
the QT and the rate-corrected QT intervals in all the groups,
independently of the anaesthesia applied (Table 3); up until
the time point at which these intervals could be measured
(see above), there was no significant difference in the QT and
the rate-corrected QT intervals in the various groups. There
was no qualitative difference between the effects of the drugs
on the QT and the rate-corrected QT interval at any time
point in any group of animals (data not shown). Similarly,
there was no qualitative difference between the results of the
two different methods of QT correction (see Electrocardio-
gram analysis and arrhythmia diagnosis) at any time point in
any group of animals (data not shown).
There was no significant difference between the Tpeak–Tend
intervals in the various groups at any of the three time points
of the measurement; phenylephrine did not prolong the
Tpeak–Tend interval significantly as compared with the base-
line in the various anaesthesia groups (Table 3). Interestingly,
dofetilide infusion in the first 2 min did not prolong the
Tpeak–Tend interval significantly as compared with the value
measured before the start of this infusion in the various
anaesthesia groups (Table 3).
The mean baseline PQ interval in the different anaesthesia
groups ranged from 61±2 to 69±2 ms and remained stable
in all groups up until the time point at which this parameter
could be measured (see above); there was no significant
Table 2 Mean arterial blood pressures (mm Hg) in anaesthetized rabbits
n 0 min 10 min Phenylephrine Phenylephrineþ dofetilide
13 min 16 min 19 min 22 min 27 min 32 min 52 min 72 min
Chlor 10 61±4 58±3 61±4 66±6 67±8 80±7 93±6 93±5 78±4 83±5
Prop 10 65±6 66±7 67±6 76±8 77±7 83±7 98±5 91±5 87±6 75±7
Pento 10 86±4*,# 84±4*,# 84±5*,# 83±5 87±5 92±5 95±5 90±6 82±8 77±8
Dof2x 10 88±3*,# 86±2*,# 80±4* 88±3 94±3*,# 95±5 107±5 94±4 84±4 76±5
Phe3x 10 84±3*,# 87±2*,# 87±2*,# 91±3 94±4*,# 101±4 131±5w 128±4w 107±4w 100±4w
Phenylephrine, time points when phenylephrine is infused at increasing rates; Phenylephrineþdofetilide, time points when phenylephrine and dofetilide are
infused simultaneously (see Figure 1 for protocol); Chlor, group of animals anaesthetized with a-chloralose (‘chloralose’ group); Prop, group of animals
anaesthetized with propofol; Pento, group of animals anaesthetized with pentobarbital (‘pentobarbital’ group); Dof2x, group of animals anaesthetized with
pentobarbital, and dofetilide is infused at a rate of 0.08 mg kg1 min1 (‘double dofetilide’ group); Phe3x, group of animals anaesthetized with pentobarbital and
the maximum phenylephrine infusion rate is 45 mg kg1 min1 (‘triple phenylephrine’ group); n, group size.
All values are means±s.e.mean.
*Po0.05 vs ‘chloralose’ group; #Po0.05 vs ‘propofol’ group; wPo0.05 vs all other groups.
Table 3 Heart rates, QT and Tpeak–Tend intervals in anaesthetized rabbits
n 0 min 10 min Phenylephrine Pheþ dof
13 min 16 min 19 min 22 min 27 min 29 min 32 min
Chlor
HR 10 279±13 268±11 266±11 263±10 257±10 248±12 231±15* 235±18 245±14
QT 10 151±4 155±4 156±4 160±4 162±3 162±4 178±9* 178±16 196±10#
TpTe 10 60±6 64±6 65±8
Prop
HR 10 258±11 260±10 260±9 258±10 258±10 251±12 232±17 217±15 227±12
QT 10 157±5 161±4 161±4 159±4 161±4 166±7 164±7 187±11# 200±11#
TpTe 10 58±5 61±6 71±9
Pento
HR 10 279±9 284±8 279±8 275±7 276±8 268±7 252±6* 245±11 228±14
QT 10 151±5 149±4 151±5 154±5 156±5 158±5 156±3* 172±6 205±16#
TpTe 10 73±6 69±6 65±10
Dof2x
HR 10 292±11 286±12 284±11 281±12 274±12 267±12 248±15* 260±16 ND
QT 10 147±5 152±5 151±6 153±5 158±5 161±5 170±8* 178±7 ND
TpTe 10 64±7 70±8 71±8
Phe3x
HR 10 278±8 272±7 272±7 271±8 264±11 260±16 ND ND ND
QT 10 157±3 158±3 161±3 160±3 161±4 165±5 ND ND ND
TpTe 10 62±4 ND ND
Phenylephrine, time points when phenylephrine is infused at increasing rates; Pheþdof, time points when phenylephrine and dofetilide are infused simultaneously
(see Figure 1 for protocol); HR, sinus heart rate (min1); RR, the electrocardiographic RR interval (ms); QT, the electrocardiographic QT interval (ms); TpTe, the
electrocardiographic Tpeak–Tend interval (ms); ND, value not determined due to the frequent occurrence of arrhythmias; n, group size.
All values are means±s.e.mean.
*Po0.05 vs the value measured before the start of phenylephrine infusion at 10 min; #Po0.05 vs the value measured before the start of dofetilide infusion at
27 min. For further details see Table 2.
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difference between the PQ values in the various groups at
any time point of the measurement. The mean baseline QRS
interval in the various groups ranged from 33±1 to 34±1 ms
and remained stable up until the time point at which it
could be measured (see above); there was no significant
difference between the QRS values in the various groups at
any time point of the measurement.
Beat-to-beat variability of the QT and the RR interval
Interestingly, none of the calculated QT variability data
differed in the various groups at baseline, during the
phenylephrine infusion and at the beginning of the
dofetilide infusion (Table 4). Within-group analysis revealed
that PNN8 and the short-term variability of the QT interval
rose significantly during the phenylephrine infusion and at
the beginning of the dofetilide infusion relative to the
respective baseline values in the ‘chloralose’ group (Table 4).
No similar increase in the QT variability parameters was seen
in the other anaesthesia groups.
The values of the beat-to-beat variability of the RR interval
did not differ statistically in the different anaesthesia groups
at baseline. In contrast, significantly lower s.d. and RMSSD
values were measured in the a-chloralose-anaesthetized
animals as compared with those in the other anaesthesia
groups during the stepwise elevation of the rate of infusion
of phenylephrine, whereas the pentobarbital-anaesthetized
animals tended to show the highest s.d. and RMSSD values
(Table 5).
Baroreflex sensitivity
At baseline, a significantly higher mean down-baroreflex
sensitivity was measured in the animals anaesthetized with
pentobarbital (‘pentobarbital’, ‘double dofetilide’ and ‘triple
phenylephrine’ groups) in comparison with those measured
in the animals anaesthetized with a-chloralose or propofol
(Table 6).
Very marked differences between the baroreflex sensiti-
vities in the various anaesthesia groups were observed during
the phenylephrine infusion, that is significantly higher up-
baroreflex sensitivity and down-baroreflex sensitivity were
measured in the animals anaesthetized with pentobarbital
(the ‘pentobarbital’, ‘double dofetilide’ and ‘triple
phenylephrine’ groups) as compared with those measured
in the animals anaesthetized with a-chloralose or propofol
(Table 6).
The spectral power of the systolic arterial pressure and the RR
interval
The baseline mid-frequency spectral power of the systolic
arterial pressure was significantly higher in the ‘pentobarbi-
tal’ group as compared with those in the ‘chloralose’ and
Table 4 The beat-to-beat variability of the QT interval in anaesthetized rabbits
N MeanQT s.d. RMSSD SDSD PNN8 Instability LTV STV QTVI
Chlor
Basal 10 166±3 7.5±1.9 7.4±1.0 7.5±1.0 9.7±1.8 12.8±4.5 7.2±2.2 3.8±0.4 1.2±0.2
Phe15 10 190±9* 8.1±0.9 9.8±1.0 9.9±1.0 17.2±2.4* 9.5±0.7 6.7±0.8 5.4±0.5* 1.2±0.2
Dof 10 198±13* 8.4±1.1 10.2±1.3 10.4±1.3 18.3±2.8* 11.2±1.8 7.2±1.1 5.5±0.7* 1.0±0.2
Prop
Basal 10 178±5 7.9±0.9 9.0±1.3 9.2±1.3 12.4±2.2 10.4±1.0 6.8±0.7 4.8±0.6 1.4±0.1
Phe15 10 183±8 6.1±0.6 7.8±0.7 7.9±0.7 13.8±2.1 7.6±1.0 5.0±0.6 4.2±0.3 0.9±0.2
Dof 10 194±7 8.0±1.4 9.2±1.2 9.4±1.2 15.9±2.7 10.3±1.9 7.0±1.6 5.1±0.7 1.2±0.2
Pento
Basal 8 168±10 8.9±1.5 11.0±2.0 11.2±2.0 16.4±4.7 12.5±2.1 7.3±1.2 5.8±1.1 1.3±0.2
Phe15 9 171±4 7.7±1.1 9.2±1.2 9.4±1.2 14.9±3.1 10.6±1.8 6.7±1.0 5.0±0.7 1.2±0.1
Dof 8 190±10*,# 10.2±1.7 11.9±1.8 12.1±1.9 20.7±4.5 12.5±2.2 8.6±1.7 6.4±1.0 1.3±0.2
Dof2x
Basal 10 172±10 5.8±0.7 6.8±0.9 6.9±0.9 7.2±2.6 7.1±1.0 4.9±0.6 3.7±0.5 1.2±0.1
Phe15 10 179±9 6.3±0.7 7.2±1.0 7.4±1.0 11.0±3.0 9.6±0.9 5.7±0.7 4.1±0.6 1.2±0.1
Dof 7 182±11 5.9±0.8 6.4±0.7 6.5±0.7 8.4±1.8 7.7±1.0 5.2±0.8 3.5±0.4 0.9±0.3
Phe3x
Basal 10 171±4 7.2±1.0 8.3±1.0 8.4±1.0 13.8±2.7 10.2±1.3 6.4±1.0 4.5±0.6 1.3±0.1
Phe15 10 179±4 6.6±0.5 8.1±0.7 8.2±0.7 14.1±2.5 9.1±0.9 5.6±0.5 4.2±0.4 0.8±0.2
Dof 3 158±24 9.0±2.2 7.8±1.8 7.9±1.9 12.6±5.7 11.7±5.2 8.4±3.3 4.2±0.9 1.1±0.2
Basal, the value determined from 30 consecutive QT intervals before drug administration; Phe15, value determined from 30 consecutive QT intervals in the last
minute of the 15 mg kg1 min1 phenylephrine infusion rate; Dof, the value measured from 30 consecutive QT intervals shortly after the beginning of the dofetilide
infusion (in the 2nd–4th minute of dofetilide infusion), when arrhythmias were still infrequent. N, number of animals in which the QT variability was determined as
there was no arrhythmia at the time point of the measurement; MeanQT, the mean of the measured 30 consecutive QT intervals (ms); s.d., the standard deviation
of the measured 30 consecutive QT intervals (ms); RMSSD, the root mean square of the successive difference of the QT intervals (ms); SDSD, standard deviation of
successive differences of the QT intervals (ms); PNN8, percentage of QT intervals differing from the preceding one by more than 8 ms (%); Instability, QT instability
(ms); LTV, long-term variability of the QT intervals (ms); STV, short-term variability of the QT intervals (ms); QTVI, QT variability index.
All values shown as means±s.e.mean.
*Po0.05 vs Basal; #Po0.05 vs Phe. For further details see Table 2.
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‘propofol’ groups (Figure 3a). Slightly lower values of the
mid-frequency spectral power of the systolic arterial pressure
were measured in all the groups during the phenylephrine
infusion and there were no statistical differences between
the values in the various groups at this time of the
experiment (Figure 3b). The mid-frequency spectral power
of the RR interval did not differ in the various groups (Figures
3c and d).
There was no statistical difference between the spectral
powers of the systolic arterial pressure in the various groups,
in either the low- or the high-frequency range, and similarly,
there was no statistical difference between the spectral
powers of the RR interval in the various groups in either
the low- or the high-frequency range (data not shown).
Discussion
This study is the first to report that pentobarbital anaesthesia
differs substantially from a-chloralose anaesthesia in terms
of anti-arrhythmic potency against drug-induced pro-ar-
rhythmia. In the present study, pentobarbital anaesthesia
reduced, whereas propofol anaesthesia did not affect, the
incidence of dofetilide-induced torsades de pointes in rabbits
relative to that seen with the standard a-chloralose anaes-
thesia. Although doubling of the dose of dofetilide increased
the pro-arrhythmic activity of the drug in the pentobarbital-
anaesthetized rabbits, the incidence of torsades de pointes
still did not reach the level achieved with half the dose of
dofetilide in the a-chloralose-anaesthetized rabbits. Interest-
ingly, even tripling of the rate of the sensitizing background
infusion of phenylephrine did not overcome the protective
effect of the pentobarbital anaesthesia. The differences
between the effects of the anaesthetics on the pro-arrhyth-
mic activity of dofetilide were not related to the blood
pressure, the heart rate or the measured parameters reflecting
the ventricular repolarization. However, in the first set of
experiments, significantly lower indices of the parasympa-
thetic and sympathetic activities were found in the groups of
animals anaesthetized with a-chloralose or propofol as
compared with those measured in the group of animals
anaesthetized with pentobarbital, which implies that a
reduced autonomic activity may predispose to drug-induced
torsades de pointes in rabbits.
Electrophysiology of pentobarbital: the possible mechanisms of the
effect against dofetilide-induced pro-arrhythmia
Pentobarbital is an inhibitor of the inward Naþ current (INa)
(Wartenberg et al., 2001). It also blocks the slow (IKs) and the
Table 5 The beat-to-beat variability of the RR interval in anaesthetized rabbits
Drug-free Phe3 Phe6 Phe9 Phe12 Phe15
Chlor
N 10 9 9 8 8 8
MeanRR 223±10 221±11 224±11 227±12 228±12 232±10
s.d. 1.6±0.2 1.4±0.1 1.3±0.1 1.3±0.1#,*,w,z 1.3±0.1*,w,z 1.6±0.2w,z
RMSSD 1.4±0.2 1.3±0.2 1.1±0.1*,z 1.2±0.1 1.4±0.2 1.5±0.2
Prop
N 10 10 9 8 9 10
MeanRR 235±9 235±8 230±8 233±10 231±9 234±8
s.d. 2.1±0.3 1.9±0.1 1.8±0.1 1.8±0.1 1.6±0.1 1.6±0.1w,z
RMSSD 1.5±0.1 1.6±0.2 1.4±0.2 1.6±0.2 1.5±0.2 1.4±0.1
Pento
N 8 8 7 8 7 6
MeanRR 217±7 212±7 218±8 215±8 212±5 219±6
s.d. 2.1±0.3 1.6±0.2 1.9±0.3 2.1±0.2 2.1±0.4 2.0±0.3z
RMSSD 1.9±0.2 1.8±0.2 1.7±0.3 2.1±0.4 1.7±0.2 1.8±0.3
Dof2x
N 10 10 10 9 9 7
MeanRR 212±9 213±8 217±10 219±11 228±11 241±15
s.d. 1.9±0.4 2.0±0.3 1.6±0.2 2.2±0.4 2.6±0.4 3.2±0.7
RMSSD 1.4±0.1 1.6±0.2 1.6±0.2 1.6±0.2 1.5±0.1 1.9±0.3
Phe3x
N 10 10 9 8 6 6
MeanRR 222±6 222±6 224±7 230±12 238±21 253±18
s.d. 2.2±0.3 2.2±0.2 1.9±0.3 2.8±0.6 2.5±0.4 3.8±0.8
RMSSD 2.0±0.3 2.2±0.3 2.2±0.6 2.3±0.8 1.8±0.1 1.5±0.2
N, number of animals in which variability of the RR interval was determined; MeanRR, mean duration of the RR intervals within the 5- or 1-min period when
measurement was taken (ms); s.d., standard deviation of RR intervals within the 5- or 1-min period when measurement was taken (ms); RMSSD, root mean square
of successive RR differences (ms); Drug-free, value determined from the consecutive RR intervals of the last 5-min period before phenylephrine infusion; Phe3,
Phe6, Phe9, Phe12 and Phe15, values determined from the consecutive RR intervals for the last 1 min of the 3, 6, 9, 12 and 15mg kg1 min1 phenylephrine
infusion rates, respectively.
All values shown as means±s.e.mean.
#Po0.05 vs ‘propofol’ group; *Po0.05 vs ‘pentobarbital’ group; wPo0.05 vs ‘double dofetilide’ group; zPo0.05 vs ‘triple phenylephrine’ group. For further details
see Table 2.
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rapid (IKr) component of the delayed rectifier K
þ current and
the inward rectifier Kþ current (IK1) with the highest affinity
for IKs (Bachmann et al., 2002). Simultaneous blockade of the
sarcolemmal Naþ and Kþ channels can provide a beneficial
effect against drug-induced torsades de pointes via suppres-
sion of the early afterdepolarizations (Wu et al., 2005).
Pentobarbital homogeneously prolonged the duration of
the action potential of the canine endo-, epi- and mid-
myocardium, which significantly reduced the ability of
repolarization-prolonging drugs to increase transmural dis-
persion of the repolarization (Shimizu et al., 1999), and thus,
similarly to our results, pentobarbital reduced the incidence
of the drug-induced torsades de pointes in arterially perfused
canine left ventricular wedge preparations (Shimizu et al.,
1999) and in dogs in vivo (Weissenburger et al., 2000;
Yamamoto et al., 2001; Voss et al., 2002). Interestingly,
pentobarbital did not reduce the almokalant-induced in-
crease in transmural dispersion of the effective refractory
period, whereas it did prevent the repolarization-prolonging
almokalant from evoking torsades de pointes in dogs in vivo
(Voss et al., 2002). Thus, it is still not fully verified whether
the anti-arrhythmic activity of pentobarbital against drug-
induced torsades de pointes is related to a reduction in the
transmural dispersion of the repolarization.
The temporal dispersion of repolarization defined as the
beat-to-beat variability of the monophasic action potential
duration has been shown to predict the pro-arrhythmic
activity of repolarization-prolonging drugs (Hondeghem
et al., 2001; Thomsen et al., 2004). In an earlier study with
isolated rabbit hearts, pentobarbital prolonged the duration
of the action potential without increasing the beat-to-beat
variability of the duration of the action potential in the
presence or in the absence of the repolarization-prolonging
sea anemone toxin ATX-II (Wu et al., 2006), which can also
explain the preventive effect of pentobarbital in the present
study.
As found in our experiments, the incidence of dofetilide-
induced torsades de pointes in a1-adrenergically stimulated
rabbits was only 50% when pentobarbital anaesthesia was
applied (Bril et al., 1996). In contrast, the incidence of
torsades de pointes induced by the selective IKr blocker
E-4031 was as high as 90% in a1-adrenergically stimulated
rabbits despite the fact that the animals were anaesthetized
with pentobarbital (Bril et al., 1996). Accordingly, the
preventive effect of pentobarbital against torsades de pointes
may be specifically related to dofetilide, but this needs
further investigations to clarify.
Electrophysiology of propofol: the lack of effect on the
dofetilide-induced pro-arrhythmia
Therapeutic concentrations of propofol inhibit INa, the
L-type Ca2þ current (ICa,L) and the transient outward K
þ
current (Ito) and delay ventricular conduction in the rabbit
(Wu et al., 1997). This combined ion channel-blocking
property should provide propofol with an anti-arrhythmic
effect against drug-induced torsades de pointes, comparable
to that of pentobarbital (Antzelevitch et al., 1999) or
Table 6 Baroreflex sensitivity in anaesthetized rabbits
Chlor Prop Pento Dof2x Phe3x
Baseline
Up-BRS
a 8 9 7 7 10
Mean 3.59±1.00 2.47±0.24 2.97±0.79 2.98±0.51 3.75±0.52
Valid 2.71±1.26 5.86±1.68 5.44±3.00 2.13±0.71 4.67±2.17
Down-BRS
b 5 8 7 7 8
Mean 1.74±0.33 1.61±0.17 3.25±0.58*,# 2.58±0.40# 2.65±0.34#
Valid 3.40±0.87 4.39±2.21 3.71±1.04 0.76±0.16 5.19±1.86
Phenylephrine
Up-BRS
c 30 42 17 30 23
Mean 2.47±0.14 2.76±0.17 5.68±1.09*,#w 3.06±0.32 3.74±0.29*,#w
Valid 5.52±0.87 5.90±0.73 6.05±1.40 5.16±1.25 3.53±0.73
Down-BRS
d 25 30 22 21 22
Mean 2.13±0.28 2.00±0.17 4.22±0.64*,# 3.95±0.53*,# 3.59±0.48*,#
Valid 4.78±0.86 6.01±1.07 5.43±0.96 4.64±0.85 4.37±1.27
Baseline, baseline baroreflex sensitivity (BRS) data determined by spontaneous up- and down-BRS sequences found in the 5-min period before the start of
phenylephrine infusion; Phenylephrine, pooled BRS data determined by spontaneous up- and down-BRS sequences found during phenylephrine infusion before
the start of dofetilide administration; Up-BRS, sequence of consecutive, constantly widening RR intervals, where the RR interval duration widening was induced by
an increase in the systolic arterial blood pressure; Down-BRS, sequence of consecutive, constantly shortening RR intervals, where the RR interval duration
shortening was induced by a decrease in the systolic arterial blood pressure; a, number of animals in which spontaneous up-BRS sequences were found before
phenylephrine infusion; b, number of animals in which spontaneous down-BRS sequences were found before phenylephrine infusion; c, number of 1-min periods
(out of the possible 50 in each group) in which spontaneous up-BRS sequences were found during stepwise elevation of the phenylephrine infusion rate; d,
number of 1-min periods (out of the possible 50 in each group) in which spontaneous down-BRS sequences were found during stepwise elevation of the
phenylephrine infusion rate; Mean, mean baroreflex sensitivity value (ms (mm Hg)1); Valid, the percentage incidence (%) of RR intervals displaying spontaneous
baroreflex sequences used to calculate baroreflex sensitivity data.
All values shown as means±s.e.mean.
*Po0.05 vs ‘chloralose’ group; #Po0.05 vs ‘propofol’ group; wPo0.05 vs ‘double dofetilide’ group. For further details see Table 2.
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amiodarone (Sicouri et al., 1997). In contrast, propofol
anaesthesia did not prevent the dofetilide-induced torsades
de pointes in the present study. A possible explanation for
this lack of an anti-arrhythmic effect is that propofol delayed
ventricular conduction (Wu et al., 1997), which might
increase the number of functioning re-entry circles in the
presence of dofetilide, thereby counteracting the beneficial
effect of the multiple ion channel-blocking property of the
drug. The lack of an anti-arrhythmic effect of the multiple
ion channel-blocking propofol against the dofetilide-
induced torsades de pointes implies that in vitro studies,
which examine only ion channel effects of drugs, can not
properly predict the anti-arrhythmic or pro-arrhythmic
activity of drugs; drug effects related to torsades de pointes
can be examined best in integrated pro-arrhythmia models
(Thomsen et al., 2006).
Electrophysiology of a-chloralose: different effects of pentobarbital
and a-chloralose on the dofetilide-induced pro-arrhythmia
Similarly to pentobarbital, a-chloralose at a concentration
of 500 mg l1, which is approximately five times higher than
the anaesthetic concentration of the drug, decreased the
transmural dispersion of the repolarization in the canine
ventricular muscle in vitro (Antzelevitch et al., 1999). This
was attributed to a possible blocking effect of the drug on the
late INa, and it was therefore suggested that caution should
be exercised in the interpretation and the extrapolation of
arrhythmia data obtained from studies involving a-chlor-
alose or pentobarbital anaesthesia (Antzelevitch et al., 1999).
In contrast, when the anaesthetic concentrations of pento-
barbital and a-chloralose were examined in dogs in vivo and
in guinea pig papillary muscles in vitro, marked differences
were found between the electrophysiological effects of the
two anaesthetics, that is pentobarbital prolonged the action
potential duration and the effective refractory period and
decreased the maximum rate of voltage change (Vmax) in
phase 0 of the action potential, whereas a-chloralose (at a
concentration of p100 mg l1) was devoid of direct electro-
physiological effects in both species (Nattel et al., 1990). This
may explain our results showing that, when anaesthetic
(and equianaesthetic) concentrations of pentobarbital and
a-chloralose are applied, there is a substantial difference
between the effects of these anaesthetics on drug-induced
pro-arrhythmia.
No relationship between the repolarization-related ECG
parameters and the dofetilide-induced pro-arrhythmia
In the present study, the QT interval did not correlate with
the pro-arrhythmic activity of dofetilide in the various
Figure 3 The spectral power of the systolic arterial pressure and the RR interval calculated in the mid-frequency range (0.15–0.5 Hz) in
anaesthetized rabbits. (a and b) The spectral power of the systolic arterial blood pressure at baseline and during phenylephrine infusion,
respectively. (c and d) The spectral power of the RR interval at baseline and during phenylephrine infusion, respectively. Chlor, group of
animals anaesthetized with a-chloralose (‘chloralose’ group); Prop, group of animals anaesthetized with propofol; Pento, group of animals
anaesthetized with pentobarbital (‘pentobarbital’ group); Dof2x, group of animals anaesthetized with pentobarbital, and dofetilide is infused
at a rate of 0.08 mg kg1 min1 (‘double dofetilide’ group; see Figure 1 for protocol); Phe3x, group of animals anaesthetized with pentobarbital
and the maximum phenylephrine infusion rate is 45mg kg1 min1 (‘triple phenylephrine’ group); Baseline, values measured before drug
administration; Phenylephrine, values measured during phenylephrine infusion at a rate of 9mg kg1 min1; SAP MF, the spectral power of the
systolic arterial pressure integrated in the mid-frequency band; RRI MF, the spectral power of the RR interval integrated in the mid-frequency
band; n, number of animals. *Po0.05 vs ‘chloralose’ and ‘propofol’ groups.
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anaesthesia groups. This is in line with the findings of others
and our own earlier results with the anaesthetized rabbit
model (Carlsson et al., 1993; Farkas and Coker, 2002; Farkas
et al., 2002) and supports the widely accepted notion that use
of the QT interval as a predictor of drug-induced pro-
arrhythmia can be grossly misleading (Hondeghem, 2006;
Thomsen et al., 2006).
The electrocardiographic Tpeak–Tend interval has been
shown to provide an index of the transmural dispersion of
the repolarization (Antzelevitch and Oliva, 2006). In our
study, dofetilide did not prolong the Tpeak–Tend interval
before the induction of frequent arrhythmias in any
anaesthesia group. Furthermore, the Tpeak–Tend interval of
the pentobarbital-anaesthetized animals did not differ from
those in the other anaesthesia groups, which indicates that
the Tpeak–Tend interval measured in the standard limb Lead II
of the ECG does not predict drug-induced pro-arrhythmia
susceptibility in anaesthetized rabbits. Further investigations
are needed to clarify whether this low predictive value of the
Tpeak–Tend interval in anaesthetized rabbits is a result of the
lack of a drug-induced increase in the transmural dispersion
of the repolarization or of the lack of any relationship
between the transmural dispersion of the repolarization and
the Tpeak–Tend interval measured in the standard limb Lead II
of the rabbit ECG.
It has been suggested that the variability of the QT interval
may reflect the beat-to-beat variability of the duration of the
action potential of the ventricular myocytes and, thus, may
predict the pro-arrhythmic liability of the repolarization-
prolonging drugs (Hondeghem, 2006). In accordance with
this, the QT interval variability increased in dogs after the
administration of pro-arrhythmic repolarization-prolonging
drugs (Schneider et al., 2005). Surprisingly, the QT variability
parameters in the different anaesthesia groups did not differ
in the present study, and hence, did not predict the pro-
arrhythmic activity of dofetilide. On the other hand, the
significant increases in PNN8 and the short-term variability
of the QT interval during phenylephrine and dofetilide
infusion may predict a higher arrhythmia susceptibility of
the a-chloralose-anaesthetized rabbits in the present study.
However, the roles of the different parameters of the QT
variability as predictors of drug-induced torsades de pointes
in rabbits demand further investigations.
The effects of the anaesthetics on the sympathetic activity
The applied rabbit model of pro-arrhythmia depends
critically on the stimulation of the a1-adrenoceptors (Carlsson
et al., 1990). Since pentobarbital does not affect the a1-
adrenoceptors, it is unlikely that the anti-arrhythmic activity
of the drug was related to a reduction of the sensitizing
a1-adrenoceptor stimulation in the present study. Interestingly,
tripling of the rate of the background phenylephrine
infusion did not affect the protective effect of pentobarbital
against the dofetilide-induced torsades de pointes, while it
elevated the blood pressure markedly. This is in accordance
with the results of earlier investigations showing that neither
an increased blood pressure (Coker and Farkas, 2004) nor the
corresponding elevated ventricular stretch (Farkas et al.,
2006) is of importance in the generation of drug-induced
torsades de pointes in rabbits.
An increased sympathetic activity may contribute to the
genesis of torsades de pointes in either the acquired or the
inherited form of the long QT syndrome (Verrier and
Antzelevitch, 2004; Schwartz, 2006). The highest baseline
blood pressure, the largest number of arrhythmias during
phenylephrine infusion and the highest baseline spectral
power of the systolic arterial pressure in the mid-frequency
range (SAP MF) were found in the animals anaesthetized
with pentobarbital in the present study. These data indicate
that the pentobarbital anaesthesia allowed a higher sympa-
thetic activity as compared with those in the animals
anaesthetized with the equianaesthetic dose of propofol or
a-chloralose. Pentobarbital (Morita et al., 1987) and propofol
(Xu et al., 2000) are known to reduce sympathetic nerve
activity. On the other hand, an earlier study revealed
elevation in the heart rate, blood pressure and serum
noradrenaline level in a-chloralose-anaesthetized rabbits,
and accordingly it was concluded that a-chloralose anaes-
thesia elevated the sympathetic activity (Pettersson et al.,
1990). However, the dose of a-chloralose applied was very
low (75 mg kg1) and the non-depolarizing muscle relaxant
pancuronium was administered to the animals after anaes-
thesia, which was followed by the surgical preparation of the
left femoral artery (Pettersson et al., 1990). Thus, it could well
have been the pain that elevated the sympathetic activity
of the rabbits rather than the a-chloralose anaesthesia in that
study. Our SAP MF data indicate that the sympathetic
activity of the a-chloralose-anaesthetized animals was low
when the anaesthetic was administered in a high dose
needed for a sufficiently deep anaesthesia. Accordingly, the
sympathetic activity of the animals was suppressed by all the
anaesthetics, but pentobarbital caused a small suppression
in the sympathetic activity relative to the other two
anaesthetics in the present study. Since the incidence of
torsades de pointes was the lowest in the pentobarbital group
(with the ‘single dofetilide’ dose), it is concluded that there is
no positive correlation between the incidence of dofetilide-
induced torsades de pointes and the activity of the
sympathetic nervous system in the animal model applied.
The effects of the anaesthetics on the vagal nerve activity
A decreased heart rate variability and a decreased baroreflex
sensitivity are predictors of arrhythmic and total cardiac
mortality after myocardial infarction and also in patients
with heart failure (Lombardi, 2002; Verrier and Antzelevitch,
2004). In the present study, the pronounced SAP MF did
not coincide with an outstanding spectral power of the RR
interval in the mid-frequency range in the pentobarbital-
anaesthetized groups, which indicates that the baroreflex
sensitivity of the pentobarbital-anaesthetized animals was
suppressed (Cevese et al., 2001). Furthermore, the a-chloralose-
and propofol-anaesthetized rabbits displayed lower variabil-
ity of the RR interval and lower baroreflex sensitivity values,
especially during the phenylephrine infusion, which indi-
cates that the vagal nerve activity of these animals was
significantly lower before the dofetilide administration than
in the pentobarbital-anaesthetized animals. Accordingly, the
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vagal nerve activity of the animals was suppressed by all the
anaesthetics, but pentobarbital suppressed it least in the
present study. This implies that a markedly decreased
parasympathetic activity might predispose the animals to
dofetilide-induced torsades de pointes, since the incidence of
this arrhythmia was high in the a-chloralose- and propofol-
anaesthetized groups. This is in accordance with earlier
results demonstrating that a decreased baroreflex sensitivity
predicted the occurrence of polymorphic ventricular tachy-
cardia induced by the repolarization-prolonging caesium
ions in rabbits (Ou et al., 1999). In contrast, isolated rabbit
hearts, which lack vagal stimulation, have a very low
susceptibility without atrioventricular blockade to dofeti-
lide-induced torsades de pointes, even when perfused with a
high concentration of the a1-adrenergic stimulant methox-
amine (Farkas et al., 2006). Thus, further investigations are
needed to verify whether there is a correlation between
decreased vagal nerve activity and the occurrence of drug-
induced torsades de pointes.
Conclusions
Pentobarbital anaesthesia reduces, whereas propofol anaes-
thesia does not affect the incidence of dofetilide-induced
torsades de pointes as compared with that seen with the
standard a-chloralose anaesthesia in rabbits. The strong
protective effect of pentobarbital against dofetilide-induced
torsades de pointes may be related to its complex cardiac
electrophysiological effects rather than its autonomic effects.
Furthermore, in rabbits, anaesthetics may affect the genesis
of drug-induced torsades de pointes differently, which must
be considered when results of different studies are compared.
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